The pharmaceutical industry’s research, development, and marketing of substances used to control hunger and regulate weight is referred to as the “Anorexiant Market.” Anorexiants are a class of drug that can assist lower appetite, which can result in less food being consumed and possible weight reduction.
The market for anorexiants largely targets those who battle with obesity or other disorders related to being overweight and require medicinal assistance to lose weight. Usually prescribed by medical practitioners, these drugs are taken in conjunction with diet and exercise regimens.
It’s vital to highlight that, as an AI language model, I have no access to market or real-time data beyond September 2021, when my knowledge will expire. As a result, I am unable to give you the most recent information on the situation or trends in the anorexic market. I advise consulting industry studies, market research companies, or healthcare specialists for current and precise market insights.
Curious about the effects of recent acquisitions in the anorexiant market industry? Download our Sample Report now @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9574
The market for anorexics was projected to reach US$1 billion in value in 2022. During the forecast period, the market for anorexiants is anticipated to expand at a CAGR of 5.3% by 2032. The rise in obesity prevalence is a result of growth. The WHO estimates that 39 million children under the age of five and 600 million people will be obese by 2021. The rising cost of healthcare as a result of this problem is expected to increase the demand for anorexics in the coming years.
Anorexiants: Market Insights:
Anorexiants are used to treat obesity. Anorexiants suppress hunger by boosting a person’s basal metabolic rate. Anorexiants also boost cellular glucose uptake while lowering fat absorption from food.
According to the World Health Organisation, more than 1.9 billion people aged 18 and older were classified as overweight in 2016, with 650 million adults classified as obese. In addition, 41 million children under the age of five were found to be obese in 2016.
Anorexiants: Market Dynamics
Because of their utility in the treatment of obesity, anorexiants are expected to grow greatly in the market. Anorexiants can aid in weight loss by reducing calorie intake, particularly in patients with a BMI of 30 or higher.
The market is expected to grow because anorexiants are used to treat obesity. Anorexics, on the other hand, are restricted in some ways. Anorexiants can have a number of unpleasant side effects, including sleepiness, elevated blood pressure, restlessness, drug dependence, and so on, which can have an effect on the Anorexiants market. Long-term use of anorexiants also leads to drug addiction, which can lead to health concerns later in life.
Don’t hesitate to contact our analyst if you have any questions @ https://www.futuremarketinsights.com/ask-question/rep-gb-9574
Anorexiants Market: Overview
Because of the rising prevalence of obesity around the world, the Anorexiants industry is expected to produce significant income in the next years. Orlistat, lorcaserinER, liraglutide, naltrexone/bupropion ER, lorcaserin, and phentermine/topiramate ER are some of the anorexiants used to treat obesity. Many drugs have been approved by the FDA for the treatment of obesity, therefore the market for anorexiants is projected to grow in the coming years.
According to the Centres for Disease Control and Prevention, the obesity prevalence in the United States is expected to be 39.8%, affecting 93.3 million people. The global Anorexiants market will grow as the prevalence and incidence of weight gain and obesity rise.
Anorexiants Market: Region-wise Outlook
Geographically, the global Anorexiants market is segmented into seven primary regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific except Japan, Japan, and the Middle East and Africa. Because of the rising prevalence of obesity and the rapid adoption of new medications, North America is expected to hold the highest proportion of the Anorexiants market.
Furthermore, the expansion of healthcare facilities and technological improvements have substantially aided the Anorexiants industry. Europe is predicted to make a considerable contribution to the Anorexiants market due to increased drug launches and easier drug approval, resulting in market growth.
Anorexiants Market: Key Players
Some of the key players present across the value chain of the global Anorexiants market are Akrimax Pharmaceuticals, LLC, Teva Pharmaceuticals, Janssen Ortho, LLC, Roche Pharmaceuticals, Arena Pharmaceuticals GmbH, Novo Nordisk A/S, Abbott Pharmaceuticals PR Ltd., Epic Pharma, LLC. Patheon Pharmaceuticals Inc. Catalent Pharma Solutions, LLC, Recordati Rare Diseases Inc., MOVA Pharmaceuticals.
Act Now to Explore In-Depth Market Analysis: Get Exclusive Purchase Now to Access @ https://www.futuremarketinsights.com/checkout/9574
Key Segments Profiled in the Anorexiants Market Survey
By Drug Class:
- Catecholaminesb
- Serotoninb
By Route of Administration:
- Oral
- Subcutaneous
By End User:
- Institutional sales
- Hospitals
- Clinics
- Retail sales
- Online pharmacies
- Mail Order Pharmacies
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
